Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 7,591 | 9,259 | 5,203 | 5,984 | 4,188 |
| Operating Income | -7,591 | -9,259 | -5,203 | -5,984 | -4,188 |
| Interest Expense | 0 | 0 | 0 | 3 | 4 |
| Other Income | 30 | 34 | 242 | 163 | 69 |
| Pre-tax Income | -7,561 | -9,225 | -4,961 | -5,824 | -4,122 |
| Net Income Continuous | -7,561 | -9,225 | -4,961 | -5,824 | -4,122 |
| Net Income | $-7,561 | $-9,225 | $-4,961 | $-5,824 | $-4,122 |
| EPS Basic Total Ops | -1.25 | -1.50 | 0.25 | -1.25 | -1.00 |
| EPS Basic Continuous Ops | -1.29 | -1.58 | 0.49 | -1.06 | -1.07 |
| EPS Diluted Total Ops | -1.25 | -1.50 | 0.25 | -1.25 | -1.00 |
| EPS Diluted Continuous Ops | -1.29 | -1.58 | 0.49 | -1.06 | -1.07 |
| EBITDA(a) | $-7,546 | $-9,216 | $-5,161 | $-5,943 | $-4,147 |